PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Multi-institutional team finds targetable mutation in rare brain tumor

BRAF mutation associated with other cancers appears to drive papillary craniopharyngiomas

2014-01-13
(Press-News.org) Contact information: Katie Marquedant
kmarquedant@partners.org
617-726-0337
Massachusetts General Hospital
Multi-institutional team finds targetable mutation in rare brain tumor BRAF mutation associated with other cancers appears to drive papillary craniopharyngiomas A team led by investigators from Massachusetts General Hospital (MGH), Brigham and Women's Hospital (BWH) and the Broad Institute has found that a gene mutation associated with several types of cancer also may be responsible for a rare but debilitating brain tumor called papillary craniopharyngioma. Their discovery, reported online in Nature Genetics, could lead to new therapies for this currently hard-to-treat tumor.

"We were delighted to find that the same BRAF mutation previously described in melanomas and other brain tumors appears to be driving the growth of these tumors," says Priscilla Brastianos, MD, of the MGH Cancer Center and the Broad Institute, co-corresponding author of the report. "BRAF inhibitors have shown great promise in treating patients with other tumors with this mutation, and we hope to quickly evaluate these drugs in patients with papillary craniopharyngioma in hopes of reducing the serious consequences of this disease."

Craniopharyngiomas arise at the base of the skull adjacent to the pituitary gland, the hypothalamus and other critical brain structures. Although they are not inherently aggressive tumors, because of their location they can significantly compromise vision and other neurologic and endocrine functions. The tumors cling to brain structures, usually making surgical removal challenging, and radiation therapy can cause vascular abnormalities or other tumors.

There are two subtypes of craniopharyngiomas – adamantinomatous tumors, which are more common in children, and papillary tumors, usually seen in adults. Recent studies have associated mutations in an oncogene called CTNNB1 with adamantinomatous tumors, but prior to this study, no information was available about the molecular drivers of the papillary subtype. In their search for possible mutations associated with papillary tumors, the research team first performed whole exome sequencing of 15 craniopharyngiomas – 12 adamantinomatous and 3 papillary. Among adamantinomatous tumors the previously identified CTNNB1 mutation was found in 11 of the 12 samples; and for the first time, the known tumor-associated BRAF mutation was identified in all three papillary tumors.

The researchers followed that finding with a targeted genotyping of tumor samples from an additional 95 patients. Among tested papillary tumors, 94 percent had the BRAF mutation, while 96 percent of the adamantinomatous tumors had the CTNNB1 mutation. The investigators also confirmed that both types of tumors had very few other mutations and that the BRAF or CTNNB1 mutations were present in all tumor cells, suggesting they occurred early in tumor development.

"There are currently no medical therapies available for craniopharyngiomas, but potent compounds that block BRAF signaling are in hand. So we are very hopeful that these targeted therapies can drastically alter the management of these tumors," says Sandro Santagata, MD, PhD, BWH Department of Pathology and a co-corresponding author of the Nature Genetics paper. "Inhibitors of the signaling pathway controlled by CTNNB1 that are currently in clinical trials should be investigated for adamantinomatous tumors, and we're planning to evaluate the BRAF inhibitors that have had promising results against melanoma for treatment of papillary craniopharyngiomas."

### Santagata is an assistant professor of Pathology, and Brastianos is an instructor in Medicine at Harvard Medical School. Along with Brastianos, the co-lead authors of the report are Amaro Taylor-Weiner, Broad Institute, and Peter Manley, MD, Dana-Farber Cancer Institute; Mark Kieran, MD, PhD, DFCI and Gad Getz, PhD, MGH Pathology and Broad Institute, are co-senior authors. David Louis, MD, chief of MGH Pathology, also made significant contributions to the study, as did additional collaborators from MGH, BWH, DFCI, Johns Hopkins University, the University of Pennsylvania, and other institutions. Support for the study includes grants from Pedals for Pediatrics and the Jared Branfman Sunflowers for Life Foundation for Pediatric Brain and Spinal Cord Research.

Brigham and Women's Hospital is a 793-bed nonprofit teaching affiliate of Harvard Medical School and a founding member of Partners HealthCare. BWH is an international leader in basic, clinical and translational research on human diseases, and has more than 1,000 physician-investigators and renowned biomedical scientists and faculty supported by nearly $650 million in funding. For the last 25 years, BWH ranked second in research funding from the National Institutes of Health among independent hospitals.

Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH conducts the largest hospital-based research program in the United States, with an annual research budget of more than $775 million and major research centers in AIDS, cardiovascular research, cancer, computational and integrative biology, cutaneous biology, human genetics, medical imaging, neurodegenerative disorders, regenerative medicine, reproductive biology, systems biology, transplantation biology and photomedicine.

The Eli and Edythe L. Broad Institute of Harvard and MIT was launched in 2004 to empower this generation of creative scientists to transform medicine. The Broad Institute seeks to describe all the molecular components of life and their connections; discover the molecular basis of major human diseases; develop effective new approaches to diagnostics and therapeutics; and disseminate discoveries, tools, methods and data openly to the entire scientific community. The Broad Institute includes faculty, professional staff and students from throughout the MIT and Harvard biomedical research communities and beyond, with collaborations spanning over a hundred private and public institutions in more than 40 countries worldwide.



ELSE PRESS RELEASES FROM THIS DATE:

Designer 'swiss-army-knife' molecule captures RNA in single cells in their natural tissue environment

2014-01-13
Designer 'swiss-army-knife' molecule captures RNA in single cells in their natural tissue environment Findings allow for better understanding of how tissue microenvironment affects gene expression in healthy and diseased cells PHILADELPHIA ...

Ultrasound directed to the human brain can boost sensory performance

2014-01-13
Ultrasound directed to the human brain can boost sensory performance Virginia Tech Carilion Research Institute scientists say ultrasound ranks with leading neuromodulation techniques in achieving spatial resolution Whales, bats, and even praying mantises use ultrasound as a sensory ...

Tweaking MRI to track creatine may spot heart problems earlier, Penn Medicine study suggests

2014-01-13
Tweaking MRI to track creatine may spot heart problems earlier, Penn Medicine study suggests Measuring creatine levels with MRI has benefits over contrast-enhanced MRI and MRS PHILADELPHIA— A new MRI method to map creatine at higher ...

Study: At-home test can spot early Alzheimer's

2014-01-13
Study: At-home test can spot early Alzheimer's Finding symptoms early is crucial to treatment, at-home paper test can help COLUMBUS, Ohio – The Self-Administered Gerocognitive Examination (SAGE test), which takes less than 15 minutes ...

School drug tests don't work, but 'positive climate' might

2014-01-13
School drug tests don't work, but 'positive climate' might PISCATAWAY, NJ – School drug testing does not deter teenagers from smoking marijuana, but creating a "positive school climate" just might, according to research reported in the ...

Brief mental training sessions have long-lasting benefits for seniors' cognition and everyday function

2014-01-13
Brief mental training sessions have long-lasting benefits for seniors' cognition and everyday function Older adults who received as few as 10 sessions of mental (cognitive) training showed improvements in reasoning ability and speed-of-processing when compared with untrained ...

Advanced radiation therapy for head and neck cancer may be better than traditional radiation at preventing side effects and cancer recurrence

2014-01-13
Advanced radiation therapy for head and neck cancer may be better than traditional radiation at preventing side effects and cancer recurrence Patients with head and neck cancer who are treated with an advanced form of radiation therapy may experience fewer side effects and ...

Study finds more targeted form of radiation improves survival in patients with head and neck cancers

2014-01-13
Study finds more targeted form of radiation improves survival in patients with head and neck cancers IMRT reduces side effects, also improves outcomes HOUSTON — Patients with cancers of the head and neck who received intensity-modulated ...

White parents more likely to use age-appropriate car seats than non-whites

2014-01-13
White parents more likely to use age-appropriate car seats than non-whites Race of parents remains a key predictor of whether children will be placed in the right safety seat, according to new U-M study Ann Arbor, Mich. — White parents reported higher ...

Fear of being too skinny may put teen boys at risk for depression, steroid use

2014-01-13
Fear of being too skinny may put teen boys at risk for depression, steroid use Steroid use more likely among depressed and bullying victims, study finds WASHINGTON – Teenage boys who think they're too skinny when they are actually a healthy weight are ...

LAST 30 PRESS RELEASES:

Cercus electric stimulation enables cockroach with trajectory control and spatial cognition training

Day-long conference addresses difficult to diagnose lung disease

First-ever cardiogenic shock academy features simulation lab

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

[Press-News.org] Multi-institutional team finds targetable mutation in rare brain tumor
BRAF mutation associated with other cancers appears to drive papillary craniopharyngiomas